Cargando…

Initial Clinical Experience with the Endologix AFX Unibody Stent Graft System for Treating Patients with Abdominal Aortic Aneurysms: A Case Controlled Comparative Study

PURPOSE: The newly designed unibody AFX endograft system for endovascular aortic aneurysm repair is the only graft with anatomical fixation to the aortic bifurcation in comparison to most other grafts that use the infrarenal neck as the main fixation point. The aim of this study was to assess the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouvelos, George N., Nana, Petroula, Bouris, Vasilios, Peroulis, Michalis, Drakou, Aikaterini, Rousas, Nikolaos, Giannoukas, Athanasios, Matsagkas, Miltiadis I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Vascular Specialist International 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374955/
https://www.ncbi.nlm.nih.gov/pubmed/28377907
http://dx.doi.org/10.5758/vsi.2017.33.1.16
_version_ 1782518973549510656
author Kouvelos, George N.
Nana, Petroula
Bouris, Vasilios
Peroulis, Michalis
Drakou, Aikaterini
Rousas, Nikolaos
Giannoukas, Athanasios
Matsagkas, Miltiadis I.
author_facet Kouvelos, George N.
Nana, Petroula
Bouris, Vasilios
Peroulis, Michalis
Drakou, Aikaterini
Rousas, Nikolaos
Giannoukas, Athanasios
Matsagkas, Miltiadis I.
author_sort Kouvelos, George N.
collection PubMed
description PURPOSE: The newly designed unibody AFX endograft system for endovascular aortic aneurysm repair is the only graft with anatomical fixation to the aortic bifurcation in comparison to most other grafts that use the infrarenal neck as the main fixation point. The aim of this study was to assess the preliminary results of the AFX stent-graft system used with infrarenal aortic component and compare them with those obtained in patients treated with a well established endograft of the same material and pure infrarenal fixation as the Gore Excluder. MATERIALS AND METHODS: A retrospective analysis of prospectively collected data from March 2014 to December 2014 identified 10 elective abdominal aortic aneurysm patients treated with the AFX endograft, in comparison to a matched group of 20 patients treated with the Excluder stent-graft. Endpoints included technical and clinical success, freedom from any secondary intervention, any type of endoleak and aneurysm related death. RESULTS: Primary technical success was achieved in all patients and no 30-day device related complications or deaths were occurred. The two groups were similar in terms of radiation burden, contrast media, duration of the procedure, post implantation syndrome and in-hospital stay. During a median follow-up period of 23 months (range, 18–26 months) there were no differences in clinical success, freedom from reintervention and aneurysm related death. No type I endoleak was observed in either group. Five of the 6 type II endoleaks (1 in the AFX and 4 in the Excluder group) spontaneously resolved, while in only one patient (Excluder) the endoleak remained without however any change in aneurysm sac diameter (log rank=0.34). CONCLUSION: The initial experience with the AFX stent graft system is promising, with successful aneurysm exclusion and good short-term results. Further and larger studies are needed to fully evaluate the sort as well as the long-term results.
format Online
Article
Text
id pubmed-5374955
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Vascular Specialist International
record_format MEDLINE/PubMed
spelling pubmed-53749552017-04-05 Initial Clinical Experience with the Endologix AFX Unibody Stent Graft System for Treating Patients with Abdominal Aortic Aneurysms: A Case Controlled Comparative Study Kouvelos, George N. Nana, Petroula Bouris, Vasilios Peroulis, Michalis Drakou, Aikaterini Rousas, Nikolaos Giannoukas, Athanasios Matsagkas, Miltiadis I. Vasc Specialist Int Original Article PURPOSE: The newly designed unibody AFX endograft system for endovascular aortic aneurysm repair is the only graft with anatomical fixation to the aortic bifurcation in comparison to most other grafts that use the infrarenal neck as the main fixation point. The aim of this study was to assess the preliminary results of the AFX stent-graft system used with infrarenal aortic component and compare them with those obtained in patients treated with a well established endograft of the same material and pure infrarenal fixation as the Gore Excluder. MATERIALS AND METHODS: A retrospective analysis of prospectively collected data from March 2014 to December 2014 identified 10 elective abdominal aortic aneurysm patients treated with the AFX endograft, in comparison to a matched group of 20 patients treated with the Excluder stent-graft. Endpoints included technical and clinical success, freedom from any secondary intervention, any type of endoleak and aneurysm related death. RESULTS: Primary technical success was achieved in all patients and no 30-day device related complications or deaths were occurred. The two groups were similar in terms of radiation burden, contrast media, duration of the procedure, post implantation syndrome and in-hospital stay. During a median follow-up period of 23 months (range, 18–26 months) there were no differences in clinical success, freedom from reintervention and aneurysm related death. No type I endoleak was observed in either group. Five of the 6 type II endoleaks (1 in the AFX and 4 in the Excluder group) spontaneously resolved, while in only one patient (Excluder) the endoleak remained without however any change in aneurysm sac diameter (log rank=0.34). CONCLUSION: The initial experience with the AFX stent graft system is promising, with successful aneurysm exclusion and good short-term results. Further and larger studies are needed to fully evaluate the sort as well as the long-term results. Vascular Specialist International 2017-03 2017-03-31 /pmc/articles/PMC5374955/ /pubmed/28377907 http://dx.doi.org/10.5758/vsi.2017.33.1.16 Text en Copyright © 2017, The Korean Society for Vascular Surgery This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kouvelos, George N.
Nana, Petroula
Bouris, Vasilios
Peroulis, Michalis
Drakou, Aikaterini
Rousas, Nikolaos
Giannoukas, Athanasios
Matsagkas, Miltiadis I.
Initial Clinical Experience with the Endologix AFX Unibody Stent Graft System for Treating Patients with Abdominal Aortic Aneurysms: A Case Controlled Comparative Study
title Initial Clinical Experience with the Endologix AFX Unibody Stent Graft System for Treating Patients with Abdominal Aortic Aneurysms: A Case Controlled Comparative Study
title_full Initial Clinical Experience with the Endologix AFX Unibody Stent Graft System for Treating Patients with Abdominal Aortic Aneurysms: A Case Controlled Comparative Study
title_fullStr Initial Clinical Experience with the Endologix AFX Unibody Stent Graft System for Treating Patients with Abdominal Aortic Aneurysms: A Case Controlled Comparative Study
title_full_unstemmed Initial Clinical Experience with the Endologix AFX Unibody Stent Graft System for Treating Patients with Abdominal Aortic Aneurysms: A Case Controlled Comparative Study
title_short Initial Clinical Experience with the Endologix AFX Unibody Stent Graft System for Treating Patients with Abdominal Aortic Aneurysms: A Case Controlled Comparative Study
title_sort initial clinical experience with the endologix afx unibody stent graft system for treating patients with abdominal aortic aneurysms: a case controlled comparative study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374955/
https://www.ncbi.nlm.nih.gov/pubmed/28377907
http://dx.doi.org/10.5758/vsi.2017.33.1.16
work_keys_str_mv AT kouvelosgeorgen initialclinicalexperiencewiththeendologixafxunibodystentgraftsystemfortreatingpatientswithabdominalaorticaneurysmsacasecontrolledcomparativestudy
AT nanapetroula initialclinicalexperiencewiththeendologixafxunibodystentgraftsystemfortreatingpatientswithabdominalaorticaneurysmsacasecontrolledcomparativestudy
AT bourisvasilios initialclinicalexperiencewiththeendologixafxunibodystentgraftsystemfortreatingpatientswithabdominalaorticaneurysmsacasecontrolledcomparativestudy
AT peroulismichalis initialclinicalexperiencewiththeendologixafxunibodystentgraftsystemfortreatingpatientswithabdominalaorticaneurysmsacasecontrolledcomparativestudy
AT drakouaikaterini initialclinicalexperiencewiththeendologixafxunibodystentgraftsystemfortreatingpatientswithabdominalaorticaneurysmsacasecontrolledcomparativestudy
AT rousasnikolaos initialclinicalexperiencewiththeendologixafxunibodystentgraftsystemfortreatingpatientswithabdominalaorticaneurysmsacasecontrolledcomparativestudy
AT giannoukasathanasios initialclinicalexperiencewiththeendologixafxunibodystentgraftsystemfortreatingpatientswithabdominalaorticaneurysmsacasecontrolledcomparativestudy
AT matsagkasmiltiadisi initialclinicalexperiencewiththeendologixafxunibodystentgraftsystemfortreatingpatientswithabdominalaorticaneurysmsacasecontrolledcomparativestudy